Primary IDH-mutant astrocytomas are predominantly lower grade (2021 CNS WHO grades 2–3) and are predominantly classified as G-CIMP-high, an epigenetic phenotype retained in ~ 70% of recurrent cases. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).